Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-02

Clinical Trial Update: Effects of Tiotropium on Walking Capacity in Patients With COPD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing tiotropium's effect on walking capacity in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spiriva (tiotropium)

Snippet

Sponsor: Laval University | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED